Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway
It is a modified GHRH(1-29) analog designed to resist enzymatic breakdown and extend duration of action through albumin binding. Key features of CJC-1295 DAC CJC-1295 with DAC: Activates the GHRH receptor on pituitary somatotroph cells Stimulates endogenous GH release Increases downstream IGF-1 signaling Binds to albumin through the DAC structure Produces sustained GH/IGF-1 effects over multiple days Because of this extended exposure, CJC-1295 DAC is usually discussed in research contexts focused on longer-duration GH-axis activation rather than short GH pulses
Compensation in GLP-1 Vision Loss Lawsuits If a claim is successful, compensation may include damages for: Medical bills and specialist care Future treatment and monitoring Lost income and reduced earning capacity Pain and suffering Permanent vision impairment Loss of independence or reduced quality of life Wrongful death damages, where applicable The value of a case depends on the harm it caused
Individual results vary and treatment must be prescribed and monitored by a licensed healthcare provider
US$ 24.93
US$ 20.33
US$ 23.81
US$ 24.92
US$ 21.28
US$ 25.15
